Target intelligence / Profile preview

Colonic motility

Molecular classification
Other
01

Overview

Colonic motility refers to the coordinated contraction and relaxation patterns of the smooth muscle in the colon that propel its contents toward elimination. This process is essential for water reabsorption and fecal formation. The regulation of colonic motility involves complex interactions between the enteric nervous system—particularly myenteric plexus neurons—smooth muscle cells, interstitial cells of Cajal (pacemaker cells), neurotransmitters such as acetylcholine and serotonin, gastrointestinal hormones like melatonin and somatostatin, as well as circadian clock genes including period 1 and period 2[2][3][5][8]. Disruption or abnormality in colonic motility underlies a range of gastrointestinal disorders such as chronic constipation and irritable bowel syndrome[4]. Drugs like loperamide act on opioid receptors within the gut wall to inhibit neural circuits responsible for propagating contractions known as colonic motor complexes[5]. While "colonic motility" describes a physiological process rather than a discrete molecular target or receptor, it is often used clinically to refer to therapeutic endpoints or disease mechanisms related to large intestine function. Note: "Colonic motility" is not a specific molecule or receptor but rather a physiological process involving multiple cell types, signaling pathways, neurotransmitters/hormones, ion channels/receptors/enzymes. Therefore, *is_target* should be false, *is_incorrect* should be true, because this entry does not correspond to an individual molecular target suitable for drug discovery or biomarker development.

Other names
Bowel motilityColon motor functionLarge intestine motilityColonic transit
02

Mechanism of action

Inhibition of enteric neuronal activity and reduction of propulsive peristaltic contractions by opioids[5]

03

Biological functions

Propulsion of luminal contentsWater reabsorptionFecal eliminationRegulation of bowel movements
04

Disease associations

ConstipationIrritable bowel syndrome (IBS)Chronic idiopathic constipationMotility disorders (general)Other
05

Interacting drugs

Loperamide (peripherally-restricted mu opioid agonist)[5]

2 more in the full profile.

Beyond the preview

Go deeper on Colonic motility.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Colonic motility.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call